SecBot SecBot

TKPHF

TAKEDA PHARMACEUTICAL CO LTD
OTC· Pharmaceutical Preparations· CIK 0001395064 Biotech & Drug Discovery
$41.22 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $41.22
1 year
+41.9%
from $29.05 · Oct 27
30 days
+11.4%
from $37.00
52-week range
$26.44–41.22
0% from high · low Nov 3
Avg volume 20D
7.4K
Oct 23 spike 61.2K
Short interest
🔒 Subscribers only
Filing reports
10
analyzed by SecBot
SecBot read BEARISH 5 reports · latest
Balance 3 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/5
Strongest BEARISH Takeda discloses that a May 18, 2026 jury verdict in the AMITIZA antitrust litigation constitutes an…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendUPTREND

    13% above its 50-day average. New closing high $41.22 on Oct 26.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 9, 2026 SEC
Takeda announced the issuance of 16,989,076 ordinary shares (10,892,917 new shares and 6,096,159 treasury shares) at…
6-K — Impact 3/10
Jun 5, 2026 SEC
Takeda revised its FY2025 consolidated financial statements to recognize a provision for legal proceedings following…
6-K — Impact 6/10
May 26, 2026 SEC
Takeda discloses that a May 18, 2026 jury verdict in the AMITIZA antitrust litigation constitutes an adjusting…
6-K — Impact 6/10

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q———$1.2T
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short

Washington

Corporate Lobbying

6 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

10 filings · 0 bullish · 4 bearish · 2 mixed · 4 neutral
All TKPHF filing & press-release reports (10)